![](/img/cover-not-exists.png)
Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies
Wagner, Nikolaus B., Weide, Benjamin, Gries, Mirko, Reith, Maike, Tarnanidis, Kathrin, Schuermans, Valerie, Kemper, Charlotte, Kehrel, Coretta, Funder, Anne, Lichtenberger, Ramtin, Sucker, Antje, HerpVolume:
7
Journal:
Journal for ImmunoTherapy of Cancer
DOI:
10.1186/s40425-019-0828-1
Date:
December, 2019
File:
PDF, 1.27 MB
2019